Plant Adaptogens: Natural Medicaments for 21 st Century?
- 20 February 2018
- journal article
- review article
- Published by Wiley in ChemistrySelect
- Vol. 3 (7) , 2196-2214
Abstract
This review is devoted to adaptogens, plant products capable of producing nonspecific responses in the human body, resulting in increasing the resistance against multiple stressors (physical, chemical or biological) and capable of having a normalizing effect to the human body. Adaptogens must be non‐toxic, harmless, capable of not influencing normal body functions more than required, and capable of treating depression, a common neuropsychiatric illness, the importance of which is increasing by number of new patients every year. Number of plants are able to produce natural compounds, which meet the criteria of becoming adaptogens. The most known of them are used in traditional medicine for centuries. This review summarizes data from several most important plant sources of adaptogens, however, it does not cover the field of adaptogens in all its variability. Based on the literature search covering the two past decades, it is focused at several most important plant species and their products, and at their proven or potential pharmacological effects in treating several important diseases.Keywords
Funding Information
- MPO (FV10599, FV20666, FV30300, TE01020080)
- BIORAF
- TACR
This publication has 147 references indexed in Scilit:
- The world ginseng market and the ginseng (Korea)Journal of Ginseng Research, 2013
- Terpenoids as Potential Anti-Alzheimer’s Disease TherapeuticsMolecules, 2012
- Ginsenosides as anticancer agents: In vitro and in vivo activities, structure–activity relationships, and molecular mechanisms of actionFrontiers in Pharmacology, 2012
- A High Content Drug Screen Identifies Ursolic Acid as an Inhibitor of Amyloid β Protein Interactions with Its Receptor CD36Journal of Biological Chemistry, 2011
- Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/DepressionNeuron, 2009
- Neurobiological mechanisms in major depressive disorderCanadian Medical Association Journal, 2009
- Protection against β-amyloid induced abnormal synaptic function and cell death by Ginkgolide JNeurobiology of Aging, 2009
- Future antidepressant targets: neurotrophic factors and related signaling cascadesDrug Discovery Today: Therapeutic Strategies, 2008
- Ginkgolides protect against amyloid-β1–42-mediated synapse damage in vitroMolecular Neurodegeneration, 2008
- 100 Years and Counting: Prospects for Defeating Alzheimer's DiseaseScience, 2006